You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LXEO Award Disclosure
Townsend Richard Nolan · SEC Form 4 · Filed Sep 28, 2026
Award
Calculated transaction value
$6.1K
Townsend Richard Nolan Chief Executive Officer
LXEO
Lexeo Therapeutics
LXEO
Transaction date
Sep 14, 2026
Public filing date
Sep 28, 2026
Filing lag
Filed 14 days later
LXEO daily price context
Close on/before transaction
$4.21
Sep 14, 2026
First close after public filing
$3.42
Sep 29, 2026
30-day return after filing
-8.48%
Through Oct 28, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,306 shares @ $2.64
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001995218-26-000017
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$6.1K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lexeo Therapeutics, Inc. LXEO | Award | Sep 24, 2026 | $0 |
| Lexeo Therapeutics, Inc. LXEO Current | Award | Sep 14, 2026 | $6.1K |